MIRAMAR BEACH, Fla. -- (BUSINESS WIRE) -- The executive leadership of Rainbow Coral Corp. (OTCBB:RBCC), a biotechnology company, is spending its week meeting with potential partners and innovators in San Francisco at one of the largest and most important biotechnology conferences in the world.
Running through Wednesday, the sixth annual Biotech Showcase is an established innovation forum for life science investors that draws industry professionals from around the globe. Executive-level delegates representing top public and private investment firms come to network and partner with emerging biotechnology and life science companies on the cutting edge.
RBCC execs will spend the conference seeking out and investigating technology innovators on the rise who could potentially help the company achieve its ambitious goals for 2014. The company’s primary focus is on drug delivery with an emphasis on personal and regenerative medicine.
"The top movers and shakers in biotechnology are all in San Francisco this week," said RBCC CEO Kimberly Palmer. "There’s no better place in the country for RBCC to make new contacts that could turn into lucrative new development partnerships than at the Biotech Showcase. It’s like an exciting early glimpse at the industry’s future."
By acquiring or partnering with up-and-coming biotech innovators, RBCC plans to be well-positioned to capitalize on the big growth in store for the industry. The company invests in new technology developed to compete in the biotechnology sector alongside Amgen (NASDAQ: AMGN), Dendreon Corporation (NASDAQ: DNDN), Smith & Nephew (NYSE: SNN) and Pharmaceutical Product Development (NASDAQ: PPDI).
For more information on RBCC’s other biotech initiatives, please visit www.rainbowbiosciences.com.
About Rainbow Biosciences
Rainbow Biosciences, LLC, is a wholly owned subsidiary of Rainbow Coral Corp. (OTCBB:RBCC). The Company continually seeks out new partnerships with biotechnology developers to deliver profitable new medical technologies and innovations. For more information on our growth-oriented business initiatives, please visit www.RainbowBioSciences.com.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.